Abstract
Chemotherapy and radiation therapy often result in reduced fertility, and patients receiving gonadotoxic treatment should be informed of options for fertility preservation and future reproduction prior to such treatment. Reproduction in the context of cancer also raises a number of ethical issues related to the welfare of both patients and offspring. This document replaces the document titled, "Fertility preservation and reproduction in cancer patients," last published in 2005 (Fertil Steril 2005;83:1622-8).
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
MeSH terms
-
Age Factors
-
Antineoplastic Agents / adverse effects*
-
Castration / adverse effects*
-
Female
-
Fertility Preservation / adverse effects
-
Fertility Preservation / methods
-
Fertility Preservation / standards*
-
Fertility* / drug effects
-
Fertility* / radiation effects
-
Gonads* / drug effects
-
Gonads* / pathology
-
Gonads* / physiopathology
-
Gonads* / radiation effects
-
Gonads* / surgery
-
Humans
-
Infertility / etiology
-
Infertility / pathology
-
Infertility / physiopathology
-
Infertility / therapy*
-
Male
-
Neoplasms / therapy*
-
Patient Care Team / standards
-
Patient Selection
-
Radiation Injuries / etiology
-
Radiation Injuries / pathology
-
Radiation Injuries / physiopathology
-
Radiation Injuries / therapy*
-
Radiotherapy / adverse effects
-
Risk Assessment
-
Risk Factors
-
Sex Factors